TGFB1 and atrial fibrillation: Transgenic mice with cardiomyocyte overexpression of a constitutively active form of TGF-β1, MHC-TGFcys33ser, were used by Verheule et al. [18] to investigate the effects of atrial fibrosis on AF susceptibility (Figure 1).